切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (05) : 557 -561. doi: 10.3877/cma.j.issn.2095-3232.2023.05.016

临床研究

ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用
孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇()   
  1. 100039 北京,解放军总医院第五医学中心肝病外科
  • 收稿日期:2023-06-11 出版日期:2023-10-10
  • 通信作者: 朱震宇
  • 基金资助:
    国家自然科学基金(92159305)

Application of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer

Lingzhan Meng, Hu Li, Peng Yu, Yanbin Yu, Li Cao, Wei Zhai, Yuan Gao, Yanling Shao, Jin Yan, Zhenyu Zhu()   

  1. Department of Hepatic Surgery, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
  • Received:2023-06-11 Published:2023-10-10
  • Corresponding author: Zhenyu Zhu
引用本文:

孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.

Lingzhan Meng, Hu Li, Peng Yu, Yanbin Yu, Li Cao, Wei Zhai, Yuan Gao, Yanling Shao, Jin Yan, Zhenyu Zhu. Application of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 557-561.

目的

探讨ICG荧光染色在原发性肝癌(肝癌)腹腔镜解剖性肝切除术中应用的可行性和安全性。

方法

回顾性分析2021年1月至2021年12月解放军总医院第五医学中心行腹腔镜解剖性肝切除术的52例肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男40例,女12例;平均年龄(56±9)岁。中国肝癌分期(CNLC)Ⅰa期34例,Ⅰb期13例,Ⅱa期5例;肿瘤直径中位数3.1(1.1~13.2)cm。术前行三维可视化重建评估,术中超声引导下行ICG荧光染色。观察术中ICG染色情况、手术和术后情况、随访情况。

结果

所有患者均顺利完成手术。52例患者中45例染色成功,7例失败;其中采用反染法32例,染色失败2例,成功率94%;采用正染法20例,染色失败5例,成功率75%。手术方式包括腹腔镜右半肝切除术5例,左半肝切除术4例,右前叶切除术7例,右后叶切除术2例,肝中叶切除术2例,Ⅴ段切除术11例,Ⅵ段切除术1例,Ⅶ段切除术11例,Ⅷ段切除术9例。手术时间279(88~447)min,术中出血量200(50~500)ml。术后住院时间(9.1±3.5)d。术后出现并发症3例,其中胆漏1例,经引流后痊愈;胸腔积液1例,经胸腔穿刺引流后痊愈;肺部感染1例,予抗感染治疗后痊愈。术后未发生出血等并发症,无术后死亡。术后随访期间2例肝内复发。

结论

ICG荧光染色应用于腹腔镜解剖性肝切除术中安全可行。反染法成功率高,正染法尤其适用于后、上肝段等困难部位的解剖性肝段切除。

Objective

To evaluate the feasibility and safety of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer (PLC).

Methods

Clinical data of 52 PLC patients who underwent laparoscopic anatomical hepatectomy in the Fifth Medical Center of Chinese PLA General Hospital from January to December 2021 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 40 patients were male and 12 female, aged (56±9) years on average. According to China Liver Cancer Staging (CNLC) System, 34 cases were classified as stage Ⅰa, 13 cases of stage Ⅰb and 5 cases of stage Ⅱa, respectively. The median tumor diameter was 3.1(1.1-13.2) cm. Three-dimensional visualization reconstruction and evaluation were performed before operation. Intraoperative ultrasound-guided ICG fluorescence staining was carried out. Intraoperative ICG staining, intraoperative and postoperative conditions, and postoperative follow-up were observed.

Results

All patients successfully completed the operation. Of 52 patients, ICG staining were performed successfully in 45 cases and failed in 7 cases. 32 patients were subject to reverse staining, and2 cases failed with a success rate of 94%. 20 cases received positive staining and 5 cases failed, with a success rate of 75%. Surgical methods included laparoscopic right hepatectomy in 5 cases, left liver resection in4 cases, right anterior lobectomy in 7 cases, right posterior lobectomy in 2 cases, middle lobe resection in2 cases, segment Ⅴ resection in 11 cases, segment Ⅵ resection in 1 case, segment Ⅶ resection in 11 cases and segment Ⅷ resection in 9 cases, respectively. The operation time was 279 (88-447) min, and intraoperative blood loss was 200 (50-500) ml. The length of postoperative hospital stay was (9.1±3.5) d. Postoperative complications occurred in 3 patients, including 1 case of bile leakage, which was treated after drainage, 1 case of pleural effusion, which was cured by thoracic puncture and drainage, and 1 case of pulmonary infection, which was healed after anti-infection treatment. No bleeding, other postoperative complications or death was observed. During postoperative follow-up, 2 cases developed intrahepatic recurrence.

Conclusions

It is safe and feasible to perform ICG fluorescence staining in laparoscopic anatomical hepatectomy. The success rate of reverse staining is high. Positive staining is especially suitable for anatomical hepatectomy of difficult segments, such as posterior and upper hepatic segments.

图1 荧光腹腔镜解剖性肝切除术前三维重建及模拟切割图注:a、b、c分别为右半肝切除、右前叶切除、右后叶切除三维重建
图2 荧光腹腔镜解剖性肝切除ICG染色方式注:a为肝Ⅶ段切除正染;b为右半肝切除反染;c为肝Ⅴ段亚段切除反染及肿瘤术前染色
[1]
Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka[J]. Ann Surg, 2015, 261(4):619-629.
[2]
Abu Hilal M, Aldrighetti L, Dagher I, et al. The Southampton Consensus Guidelines for laparoscopic liver surgery: from indication to implementation[J]. Ann Surg, 2018, 268(1):11-18.
[3]
Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection[J]. World J Surg, 2008, 32(8):1763-1767.
[4]
Xu Y, Chen M, Meng X, et al. Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center[J]. Surg Endosc, 2020, 34(10):4683-4691.
[5]
Liang X, Zheng J, Xu J, et al. Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it[J]. HPB, 2021, 23(9):1392-1399.
[6]
Aoki T, Koizumi T, Mansour DA, et al. Ultrasound-guided preoperative positive percutaneous indocyanine green fluorescence staining for laparoscopic anatomical liver resection[J]. J Am Coll Surg, 2020, 230(3):e7-12.
[7]
Otsuka Y, Matsumoto Y, Ito Y, et al. Intraoperative guidance using ICG fluorescence imaging system for safe and precise laparoscopic liver resection[J]. Minerva Surg, 2021, 76(3):211-219.
[8]
Xu H, Liu F, Hao X, et al. Laparoscopically anatomical versus non-anatomical liver resection for large hepatocellular carcinoma[J]. HPB, 2020, 22(1):136-143.
[9]
赵学勤, 朴纪颖, 张秉武, 等. 腹腔镜解剖性肝切除术与非解剖性肝切除术的前瞻性对比研究[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(6):581-584.
[10]
Haruki K, Furukawa K, Fujiwara Y, et al. Effectiveness of anatomical resection for small hepatocellular carcinoma: a propensity score-matched analysis of a multi-institutional database[J]. J Gastrointest Surg, 2021, 25(11):2835-2841.
[11]
王晓耘, 马增辉, 史佩东. 解剖性肝段切除术关键技术和争议[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(4):317-320.
[12]
蔡柳新, 姜文斌. 腹腔镜Glisson蒂横断式肝切除[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(4):357-359.
[13]
王晓颖, 高强, 朱晓东, 等. 腹腔镜超声联合三维可视化技术引导门静脉穿刺吲哚菁绿荧光染色在精准解剖性肝段切除术中的应用[J]. 中华消化外科杂志, 2018, 17(5):452-458.
[14]
Ito D, Ishizawa T, Hasegawa K. Laparoscopic positive staining of hepatic segments using indocyanine green-fluorescence imaging[J].J Hepatobiliary Pancreat Sci, 2020, 27(7):441-443.
[15]
Felli E, Ishizawa T, Cherkaoui Z, et al. Laparoscopic anatomical liver resection for malignancies using positive or negative staining technique with intraoperative indocyanine green-fluorescence imaging[J]. HPB, 2021, 23(11):1647-1655.
[16]
Li WF, Al-Taher M, Yu CY, et al. Super-selective intra-arterial indocyanine green administration for near-infrared fluorescence-based positive staining of hepatic segmentation: a feasibility study[J]. Surg Innov, 2021, 28(6):669-678.
[17]
Ueno M, Hayami S, Sonomura T, et al. Concomitant use of indocyanine green fluorescence imaging and interventional radiology for detection of liver segments during laparoscopic anatomical liver resection: pilot feasibility study[J]. Surg Laparosc Endosc Percutan Tech, 2019, 29(4):242-246.
[18]
Monden K, Sadamori H, Hioki M, et al. Intrahepatic Glissonean approach for laparoscopic bisegmentectomy 7 and 8 with root-side hepatic vein exposure[J]. Ann Surg Oncol, 2022, 29(2):970-971.
[19]
中国研究型医院学会微创外科学专业委员会,《腹腔镜外科杂志》编辑部. 吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志, 2019, 24(5):388-394.
[20]
Wakabayashi T, Cacciaguerra AB, Abe Y, et al. Indocyanine green fluorescence navigation in liver surgery: a systematic review on dose and timing of administration[J]. Ann Surg, 2022, 275(6):1025-1034.
[1] 韩丹, 王婷, 肖欢, 朱丽容, 陈镜宇, 唐毅. 超声造影与增强CT对儿童肝脏良恶性病变诊断价值的对比分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 939-944.
[2] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[3] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[4] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[5] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[6] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[7] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[8] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[9] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[10] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[11] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[12] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[13] 林文斌, 郑泽源, 郑文能, 郁毅刚. 外伤性脾破裂腹腔镜脾切除术患者中转开腹风险预测模型构建[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 619-623.
[14] 牛朝, 李波, 张万福, 靳文帝, 王春晓, 李晓刚. 腹腔镜袖状胃切除联合胆囊切除治疗肥胖合并胆囊结石安全性和疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 635-639.
[15] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
阅读次数
全文


摘要